Consolidated Statement of Shareholders' Equity - USD ($) shares in Millions, $ in Millions		Total	Change in accounting principle	[1]	Total U.S. Bancorp Shareholders’ Equity	Total U.S. Bancorp Shareholders’ Equity Change in accounting principle	[1]	Common Stock	Preferred Stock	Capital Surplus	Retained Earnings	Retained Earnings Change in accounting principle	[1]	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interests
Beginning Balance (in shares) at Dec. 31, 2022								1,531
Beginning Balance at Dec. 31, 2022		$ 51,232	$ 46		$ 50,766	$ 46		$ 21	$ 6,808	$ 8,712	$ 71,901	$ 46		$ (25,269)	$ (11,407)	$ 466
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		1,704			1,698						1,698					6
Other comprehensive income (loss)		1,254			1,254										1,254
Preferred stock dividends	[2]	(98)			(98)						(98)
Common stock dividends		(740)			(740)						(740)
Issuance of common and treasury stock (in shares)								3
Issuance of common and treasury stock		6			6					(114)				120
Purchase of treasury stock (in shares)								(1)
Purchase of treasury stock		(44)			(44)									(44)
Distributions to noncontrolling interests		(7)														(7)
Stock option and restricted stock grants		101			101					101
Ending Balance (in shares) at Mar. 31, 2023								1,533
Ending Balance at Mar. 31, 2023		53,454			52,989			$ 21	6,808	8,699	72,807			(25,193)	(10,153)	465
Beginning Balance (in shares) at Dec. 31, 2023								1,558
Beginning Balance at Dec. 31, 2023		55,771			55,306			$ 21	6,808	8,673	74,026			(24,126)	(10,096)	465
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		1,326			1,319						1,319					7
Other comprehensive income (loss)		(257)			(257)										(257)
Preferred stock dividends	[3]	(102)			(102)						(102)
Common stock dividends		(770)			(770)						(770)
Issuance of common and treasury stock (in shares)								3
Issuance of common and treasury stock		13			13					(139)				152
Purchase of treasury stock (in shares)								(1)
Purchase of treasury stock		(49)			(49)									(49)
Distributions to noncontrolling interests		(7)														(7)
Stock option and restricted stock grants		108			108					108
Ending Balance (in shares) at Mar. 31, 2024								1,560
Ending Balance at Mar. 31, 2024		$ 56,033			$ 55,568			$ 21	$ 6,808	$ 8,642	$ 74,473			$ (24,023)	$ (10,353)	$ 465

[1] Effective January 1, 2023, the Company adopted accounting guidance which removed the separate recognition and measurement of troubled debt restructurings. Upon adoption, the Company reduced its allowance for credit losses and increased retained earnings net of deferred taxes through a cumulative-effect adjustment.

[2] Reflects dividends declared per share on the Company’s Series A, Series B, Series J, Series K, Series L, Series M, Series N and Series O Non-Cumulative Perpetual Preferred Stock of $1,462.428, $339.357, $662.50, $343.75, $234.375, $250.00, $231.25 and $281.25, respectively.

[3] Reflects dividends declared per share on the Company’s Series A, Series B, Series J, Series K, Series L, Series M, Series N and Series O Non-Cumulative Perpetual Preferred Stock of $1,667.221, $390.264, $662.50, $343.75, $234.375, $250.00, $231.25, and $281.25, respectively.